{"id":1933,"date":"2026-08-28T15:00:00","date_gmt":"2026-08-28T15:00:00","guid":{"rendered":"https:\/\/lotilabs.com\/resources\/?p=1933"},"modified":"2026-09-01T16:10:09","modified_gmt":"2026-09-01T16:10:09","slug":"substance-p-nk1-receptor-signaling-nociception-research-neuroinflammation-pathways","status":"publish","type":"post","link":"https:\/\/lotilabs.com\/resources\/substance-p-nk1-receptor-signaling-nociception-research-neuroinflammation-pathways\/","title":{"rendered":"Substance P: NK1 Receptor Signaling, Nociception Research &#038; Neuroinflammation Pathways"},"content":{"rendered":"<div class=\"ez-toc-v2_0_83 counter-hierarchy ez-toc-counter ez-toc-light-blue ez-toc-container-direction\" id=\"ez-toc-container\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<p><span class=\"ez-toc-title-toggle\"><a aria-label=\"Toggle Table of Content\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" href=\"#\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg class=\"list-377408\" fill=\"none\" height=\"20px\" style=\"fill: #999;color:#999\" viewbox=\"0 0 24 24\" width=\"20px\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg baseprofile=\"tiny\" class=\"arrow-unsorted-368013\" height=\"10px\" style=\"fill: #999;color:#999\" version=\"1.2\" viewbox=\"0 0 24 24\" width=\"10px\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"><\/path><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav>\n<ul class=\"ez-toc-list ez-toc-list-level-1\">\n<li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/lotilabs.com\/resources\/substance-p-nk1-receptor-signaling-nociception-research-neuroinflammation-pathways\/#The_Neuropeptide_That_Named_a_Problem\">The Neuropeptide That Named a Problem<\/a><\/li>\n<li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/lotilabs.com\/resources\/substance-p-nk1-receptor-signaling-nociception-research-neuroinflammation-pathways\/#Pain_Transmission_The_Classic_Role\">Pain Transmission: The Classic Role<\/a><\/li>\n<li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/lotilabs.com\/resources\/substance-p-nk1-receptor-signaling-nociception-research-neuroinflammation-pathways\/#The_Gut_The_Second_Brain_Connection\">The Gut: The Second Brain Connection<\/a><\/li>\n<li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/lotilabs.com\/resources\/substance-p-nk1-receptor-signaling-nociception-research-neuroinflammation-pathways\/#Emesis_and_the_NK1_Antagonist_Story\">Emesis and the NK1 Antagonist Story<\/a><\/li>\n<\/ul>\n<\/nav>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"The_Neuropeptide_That_Named_a_Problem\"><\/span><span class=\"ez-toc-section\" id=\"The_Neuropeptide_That_Named_a_Problem\"><\/span>The Neuropeptide That Named a Problem<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Substance P holds a peculiar place in peptide history. Decades passed before its 11-amino-acid sequence was finally determined in 1971 by Susan Leeman and Michael Chang. In those intervening years, the placeholder name stuck : one of science\u2019s lasting accidents of nomenclature.<\/p>\n<p>Substance P belongs to the tachykinin family, a group of neuropeptides sharing a conserved C-terminal sequence (Phe-X-Gly-Leu-Met-NH\u2082) essential for receptor binding. Its primary receptor, neurokinin-1 (NK1), is a G-protein-coupled receptor distributed across the central and peripheral nervous systems, immune organs, and the gastrointestinal tract.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Pain_Transmission_The_Classic_Role\"><\/span><span class=\"ez-toc-section\" id=\"Pain_Transmission_The_Classic_Role\"><\/span>Pain Transmission: The Classic Role<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Substance P\u2019s most established function is as a neurotransmitter in pain circuits. Small-diameter sensory neurons : C-fibers and a subset of A\u03b4-fibers : synthesize substance P in their cell bodies in dorsal root ganglia and transport it to both peripheral and central terminals. At the spinal cord, substance P is released from primary afferent terminals into the dorsal horn, where NK1 activation on second-order neurons amplifies nociceptive signaling.<\/p>\n<p>This amplification is slow and sustained. The functional consequence is wind-up : a progressive increase in neuronal firing in response to repeated C-fiber stimulation. Wind-up contributes to central sensitization, a state in which normally innocuous stimuli begin to produce nociceptive responses.<\/p>\n<p>Ablation studies powerfully demonstrated substance P\u2019s role. This dissociation between acute and pathological pain processing has been a major finding in the nociception field.<\/p>\n<p>Substance P\u2019s peripheral functions extend well beyond pain signaling. When released from sensory nerve endings in the skin, joints, and airways, substance P triggers neurogenic inflammation : a process characterized by vasodilation, plasma protein extravasation, and immune cell recruitment. The peptide directly degranulates mast cells, stimulating histamine release and amplifying the local inflammatory response.<\/p>\n<p>The mechanism involves both NK1-dependent and NK1-independent pathways. Substance P binds NK1 on endothelial cells, increasing vascular permeability through gap formation between endothelial junctions. Simultaneously, it acts on mast cells through a charge-based interaction with Mas-related G-protein-coupled receptor X2 (MRGPRX2), triggering degranulation without requiring classical IgE-mediated activation.<\/p>\n<p>In airway research models, substance P released from bronchial C-fibers contributes to bronchoconstriction, mucus secretion, and submucosal edema. These effects have made NK1 receptor antagonism a research strategy in respiratory biology, although the complexity of overlapping tachykinin contributions (substance P, neurokinin A, neurokinin B) has complicated receptor-selective approaches.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"The_Gut_The_Second_Brain_Connection\"><\/span><span class=\"ez-toc-section\" id=\"The_Gut_The_Second_Brain_Connection\"><\/span>The Gut: The Second Brain Connection<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The enteric nervous system contains substantial substance P-expressing circuitry. In the gastrointestinal tract, substance P stimulates smooth muscle contraction, promotes epithelial ion secretion, and modulates gut motility through local reflex arcs. NK1 receptors on interstitial cells of Cajal : the pacemaker cells of gut motility : respond to substance P by increasing the frequency and amplitude of slow waves that drive peristalsis.<\/p>\n<p>Research into gut-brain communication has revealed that substance P-containing vagal afferents transmit visceral sensory information from the gut to the brainstem. In models of intestinal inflammation, substance P release from both intrinsic and extrinsic neurons amplifies mucosal immune activation, creating a neuroimmune feedback loop that sustains inflammatory states.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Emesis_and_the_NK1_Antagonist_Story\"><\/span><span class=\"ez-toc-section\" id=\"Emesis_and_the_NK1_Antagonist_Story\"><\/span>Emesis and the NK1 Antagonist Story<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>One of the most commercially successful applications of substance P research was the development of NK1 receptor antagonists as antiemetics. Substance P and NK1 receptors are concentrated in the nucleus tractus solitarius and area postrema : brainstem regions controlling the vomiting reflex. NK1 activation in these areas contributes to both acute and delayed emesis in research models studying nausea-inducing stimuli.<\/p>\n<p>The compound aprepitant, an NK1 antagonist, demonstrated robust anti-emetic activity in primate models, leading to its widespread research characterization. This represented a validation of the substance P\/NK1 pathway as a legitimate functional target : a journey from von Euler\u2019s mysterious \u201cpowder\u201d in 1931 to precision receptor pharmacology nine decades later.<\/p>\n<p> Substance P may have evolved not merely to signal \u201csomething is wrong\u201d but to simultaneously begin the process of fixing it.<\/p>\n<p><em>Disclaimer: This content is intended for research purposes only and is not meant to constitute medical advice.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Table of Contents Toggle The Neuropeptide That Named a Problem Pain Transmission: The Classic Role The Gut: The Second Brain Connection Emesis and the NK1 Antagonist Story The Neuropeptide That Named a Problem Substance P holds a peculiar place in peptide history. Decades passed before its 11-amino-acid sequence was finally determined in 1971 by Susan [&#8230;]\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-1933","post","type-post","status-publish","format-standard","hentry","category-peptides"],"_links":{"self":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/posts\/1933","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/comments?post=1933"}],"version-history":[{"count":0,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/posts\/1933\/revisions"}],"wp:attachment":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/media?parent=1933"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/categories?post=1933"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/tags?post=1933"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}